The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials

The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials

Objective. DC-CIK therapy included DC-CIK cells and Ag-DC-CIK cells. To further confirm whether DC-CIK reconstructs the antitumor immunity and improves the tumor responses and reveals its optimal usage and combination with chemotherapy, we systematically reevaluated all the related studies. Material...

Full description

Bibliographic Details
Main Authors: Zheng Xiao, Cheng-qiong Wang, Ming-hua Zhou, Na-na Li, Yong-ping Sun, Yu-zhi Wang, Shi-yu Liu, Hong-song Yu, Cheng-wen Li, Xian-tao Zeng, Ling Chen, Xin-sheng Yao, Ji-hong Feng
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2018/9081938

Internet

http://dx.doi.org/10.1155/2018/9081938

Similar Items